M
Michael Rosenkranz
Researcher at University of Hamburg
Publications - 48
Citations - 1926
Michael Rosenkranz is an academic researcher from University of Hamburg. The author has contributed to research in topics: Stroke & Thrombolysis. The author has an hindex of 21, co-authored 46 publications receiving 1668 citations.
Papers
More filters
Journal ArticleDOI
DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study
Götz Thomalla,Bastian Cheng,Martin Ebinger,Qing Hao,Thomas Tourdias,Ona Wu,Jong S. Kim,Lorenz Breuer,Oliver C. Singer,Steven Warach,Soren Christensen,András Treszl,Nils D. Forkert,Ivana Galinovic,Michael Rosenkranz,Tobias Engelhorn,Martin Köhrmann,Matthias Endres,Dong-Wha Kang,Vincent Dousset,A. Gregory Sorensen,David S Liebeskind,Jochen B. Fiebach,Jens Fiehler,Christian Gerloff +24 more
TL;DR: In this article, a mismatch in visibility of acute ischaemic lesion between diffusion-weighted MRI (DWI) and fluid-attenuated inversion recovery (FLAIR) MRI was used to detect patients within the recommended time window for thrombolysis.
Journal ArticleDOI
Negative fluid-attenuated inversion recovery imaging identifies acute ischemic stroke at 3 hours or less.
Götz Thomalla,Philipp Rossbach,Michael Rosenkranz,Susanne Siemonsen,Anna Krützelmann,Jens Fiehler,Christian Gerloff +6 more
TL;DR: The use of fluid‐attenuated inversion recovery (FLAIR) imaging as surrogate marker of lesion age within the first 6 hours of ischemic stroke is evaluated.
Journal ArticleDOI
Herpes simplex virus–1 encephalitis can trigger anti-NMDA receptor encephalitis: Case report
Frank Leypoldt,Maarten J. Titulaer,Esther Aguilar,Janine Walther,Marlene Bönstrup,Stefanie Havemeister,Bianca Teegen,Marc Lütgehetmann,Michael Rosenkranz,Tim Magnus,Josep Dalmau +10 more
TL;DR: An adult with this disorder is reported, it is demonstrated that synthesis of NMDAR antibodies began after HSVE, and relapsing symptoms were due to steroid-responsive anti-NMDAR encephalitis.
Journal ArticleDOI
Two Tales: Hemorrhagic Transformation but Not Parenchymal Hemorrhage After Thrombolysis Is Related to Severity and Duration of Ischemia. MRI Study of Acute Stroke Patients Treated With Intravenous Tissue Plasminogen Activator Within 6 Hours
Götz Thomalla,Jan Sobesky,Martin Köhrmann,Jochen B. Fiebach,Jens Fiehler,Olivier Zaro Weber,Anna Kruetzelmann,Thomas Kucinski,Michael Rosenkranz,Joachim Röther,Peter D. Schellinger +10 more
TL;DR: The results further support the concept of a different pathogenesis for hemorrhagic transformation and parenchymal hemorrhage, which appears to be related to biologic effects of tissue plasminogen activator and other pre-existing pathologic conditions, which deserve further investigation.
Journal ArticleDOI
AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke
Wolf-Rüdiger Schäbitz,Rico Laage,Gerhard Vogt,Winfried Koch,Rainer Kollmar,Stefan Schwab,Dietmar Schneider,Gerhard F. Hamann,Michael Rosenkranz,Roland Veltkamp,Jochen B. Fiebach,Werner Hacke,James C. Grotta,Marc Fisher,Armin Schneider +14 more
TL;DR: G-CSF was well-tolerated even at high dosages in patients with acute ischemic stroke, and that a substantial increase in leukocytes appears not problematic in stroke patients, and exploratory analyses suggest treatment effects in Patients with larger baseline diffusion-weighted imaging lesions.